Quantcast

Latest Clinical research Stories

2014-07-12 23:04:22

On June 19, the FDA added Gold Vigra and Miraculous Evil Root to its previous notification not to use specific male sexual enhancement products due to undeclared drug ingredients. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) July 11, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Male Sexual...

2014-07-11 23:01:56

A recent regulatory filing exposes that the number of adverse events in 2013 reported by patients taking Acthar was almost 14% of prescriptions. Zoll, Kranz & Borgess is investigating this potentially dangerous drug. Toledo, Ohio (PRWEB) July 11, 2014 As reported by the New York Times (Morgenson 7/10/14) and FiercePharma (Weintraub 7/11/14), a significant number of severe adverse events such as renal failure, increases in blood sugar, abdominal issues and even death from the...

2014-07-11 08:24:57

SYDNEY and BEDMINSTER, N.J., July 11, 2014 /PRNewswire/ -- QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) today provided feedback on its 9 July End-of-Review (EOR) meeting with the United States Food and Drug Administration (FDA). The meeting was held to discuss the feasibility and requirements for approving Moxduo, an immediate release Dual Opioid(®), for the treatment of moderate to severe acute pain. In advance of the meeting, QRxPharma outlined several questions to discuss with...

2014-07-10 23:13:03

On July 9, the FDA notified consumers not to purchase or use certain weight loss products including Mix Fruit Slimming, Lingzhi Cleansed Slim Tea, 24 Ince, Lipo 8 Burn Slim Capsules, Sliming (sic) Diet By Pretty White, and Trim-Fast Slimming Softgel. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) July 10, 2014 AttorneyOne.com, a recognized authority on law, update the website daily...

2014-07-09 23:08:49

Innovation Breakdown, a new book by Joseph V. Gulfo, details a broken system and how even the smallest changes can speed up the time to market for medical innovations that save lives. New York, NY (PRWEB) July 09, 2014 Joseph V. Gulfo​, MD MBA​ has successfully brought three medical innovations through the FDA over the course of his 25 year career. But the third time became a decade-long struggle of Herculean proportions, that included an​ unlawful ​withholding of approval by the...

2014-07-09 16:28:10

Study calls for more focus on long-term outcomes in pediatric trials of drugs intended for chronic use BOSTON, July 9, 2014 /PRNewswire-USNewswire/ -- Over the last 60 years, the U.S. Food and Drug Administration (FDA) approved 20 medications for attention deficit/hyperactivity disorder (ADHD) based on clinical trials that were not designed to study their long-term efficacy and safety or to detect rare adverse events, researchers at Boston Children's Hospital report today in PLOS...

2014-07-09 08:28:06

REDWOOD CITY, Calif., July 9, 2014 /PRNewswire/ -- Coherus BioSciences, Inc. ("Coherus"), announced today the appointment of V. Bryan Lawlis, Jr., Ph.D., former President and CEO of Itero Biopharmaceuticals, to its Board of Directors. "It is a privilege to join this talented Board of Directors, and I am excited about the opportunity to work with the Board and management to make Coherus the leader in the emerging business of biosimilars," Dr. Lawlis stated. "I look forward to working...

2014-07-08 23:14:36

On July 2, the FDA announced that Medtronic Duet External Drainage and Monitoring System is recalled (Class I). In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) July 08, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Medtronic Duet External Drainage and Monitoring System. The FDA informed on July 2,...

2014-07-08 23:08:23

ReportsnReports.com adds “PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market” to its store. Lucrative Biosimilars Space to Erode Biologics Market from 2019. Dallas, Texas (PRWEB) July 08, 2014 The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market beyond 2019, despite an initial projected Compound Annual Growth Rate (CAGR) of 8.3%, taking the overall biologics market value from $162 billion in...

2014-07-08 12:28:45

CHARLOTTE, N.C., July 8, 2014 /PRNewswire/ -- UniStrip Technologies, LLC of Charlotte NC has filed an antitrust lawsuit in the Los Angeles federal court against LifeScan, Inc., a Johnson & Johnson Company, for violations of the Sherman and Clayton Acts. In November, 2013 the FDA cleared UniStrip to market test strips that are compatible with four of LifeScan's OneTouch Ultra blood glucose meters. The key to UniStrip's success would be its highly accurate strips, as cleared by...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related